Jointown Pharmaceutical Group Co., Ltd. (600998.SH) Latest Company News

Oct 29, 2026, 09:19 UTC
Joinn Laboratories, Joinn Biologics and Sheng Tong Intelligence signed a strategic cooperation agreement with Jointown Pharmaceutical Group to collaborate on drug research and sales, early-stage project investment, AI healthcare and a biopharmaceutical industrial park.
Source:
- finance.sina.cn
Oct 29, 2026, 08:26 UTC
Jointown Pharmaceutical Group signed a three-year strategic cooperation agreement with WuXi AppTec, WuXi AppTec's subsidiary, and Sheng Tong Intelligence to cooperate in drug research and sales, early-stage investment, AI healthcare, and biopharmaceutical industrial parks.
Source:
- finance.sina.cn
Oct 29, 2026, 08:26 UTC
Jiuzhoutong chairman Liu Changyun and vice chairman and general manager Gong Yihua bought a combined 395,300 company shares through centralized bidding, for a total of RMB 2.0318 million.
Source:
- finance.sina.cn
Oct 19, 2026, 09:10 UTC
Jiuzhoutong and its subsidiaries obtained seven patents from the China National Intellectual Property Administration in the third quarter of 2026: one invention patent, four utility model patents and two design patents.
Source:
- finance.sina.cn
Oct 12, 2026, 02:47 UTC
Beijing Haizhi Technology Group Co., Ltd. and Jointown Pharmaceutical Group entered into a strategic cooperation framework agreement to support digital transformation in pharmaceutical distribution, including AI applications and intelligent decision support for Jointown’s supply chain.
Source:
- aastocks.com
Sep 28, 2026, 08:37 UTC
Chuchang Investment, controlling shareholder of Jointown Pharmaceutical Group, released a pledge of 88 million shares (1.75% of total share capital) on September 23, 2026, while concert party Beijing Dianjin plans to pledge 88 million shares (1.75%) to Ping An Bank Wuhan Branch.
Source:
- finance.sina.cn
Sep 16, 2026, 07:34 UTC
Beijing Haomei Digital Intelligent Medical Health Technology Co., Ltd. was established, jointly held by Beijing Haoyao Shi Pharmacy Chain Co., Ltd. (a Jiuzhoutong subsidiary) and Ningbo Niannian Youyu E-commerce Co., Ltd. (a Beingmate wholly-owned subsidiary).
Sep 11, 2026, 09:12 UTC
Shanghai Junda Hengchang increased its capital contribution to Chuchang Group, the controlling shareholder of Jointown Pharmaceutical Group, raising Chuchang Group's registered capital to 112.5347 million yuan and giving Shanghai Junda Hengchang a 1.0028% stake, with Liu Baolin, Liu Shulin and Liu Zhaonian holding 50.8233%, 25.5976% and 22.5763% respectively.
Source:
- finance.sina.cn
Sep 3, 2026, 12:07 UTC
On September 3, 2026, Jiuzhoutong Pharmaceutical Group signed a strategic cooperation agreement with JD Health to deepen collaboration in supply chain, fulfillment, consumer scenarios, and digital procurement.
Source:
- finance.sina.cn
Sep 1, 2026, 12:32 UTC
On August 31, 2026, Shanghai Waigaoqiao Group visited Jiuzhoutong Pharmaceutical Group's Wuhan headquarters and the two parties signed a cooperation agreement covering biopharmaceutical industry ecosystem, cross-border expansion and ODI services, and industrial fund cooperation.
Source:
- finance.sina.cn
Aug 28, 2026, 08:53 UTC
Jointown's controlled subsidiary Jointown Medical Health Technology Co., Ltd. won the bid for the Changyang Tujia Autonomous County county-level medical community information integration construction project, with a winning bid amount of 43.1205 million yuan and a contract performance period of 730 calendar days from the date of contract signing.
Source:
- finance.sina.cn
Aug 21, 2026, 12:34 UTC
Jiuzhoutong signed a strategic cooperation agreement with National Pension Insurance on August 21, 2026, to collaborate in areas such as pension finance and pharmaceutical services.
Source:
- finance.sina.cn
- wap.eastmoney.com
Aug 20, 2026, 09:32 UTC
Shareholder Zhongshan Guangyin of Jointown Pharmaceutical Group prematurely released a pledge of 47 million shares and pledged 17 million and 42 million shares to China Merchants Bank Wuhan Branch and Ping An Bank Wuhan Branch respectively.
Source:
- finance.sina.cn
Jul 28, 2026, 10:08 UTC
Jointown Pharmaceutical Group plans to conduct domestic non-recourse seller factoring business with a total limit of up to 2.2 billion yuan at Minsheng Bank Wuhan Branch, with the limit revolving for three years from the date of shareholder approval.
Source:
- finance.sina.cn
Jul 24, 2026, 09:58 UTC
Jiuzhou Tong's controlling shareholder Chuchang Investment and its concert parties partially released and newly pledged shares.
Source:
- finance.sina.cn
Jul 23, 2026, 12:39 UTC
Beijing Yingnuote Biotechnology Co., Ltd. has entered into a strategic partnership with Taobao Flash Sale, Ali Health, Jointown, and Ant Afu, focusing on respiratory test reagent categories to build a full-chain instant retail ecosystem.
Source:
- finance.sina.cn
Jul 15, 2026, 12:26 UTC
Haikou City Government, Hainan Medical University, and Jointown Pharmaceutical Group signed a strategic cooperation agreement to jointly build a full-chain biomedical innovation industry ecosystem.
Source:
- finance.sina.cn

600998.SH

Joinn Laboratories, Joinn Biologics and Sheng Tong Intelligence signed a strategic cooperation agreement with Jointown Pharmaceutical Group to collaborate on drug research and sales, early-stage project investment, AI healthcare and a biopharmaceutical industrial park.

Jointown Pharmaceutical Group signed a three-year strategic cooperation agreement with WuXi AppTec, WuXi AppTec's subsidiary, and Sheng Tong Intelligence to cooperate in drug research and sales, early-stage investment, AI healthcare, and biopharmaceutical industrial parks.

Jiuzhoutong chairman Liu Changyun and vice chairman and general manager Gong Yihua bought a combined 395,300 company shares through centralized bidding, for a total of RMB 2.0318 million.

Jiuzhoutong and its subsidiaries obtained seven patents from the China National Intellectual Property Administration in the third quarter of 2026: one invention patent, four utility model patents and two design patents.

Beijing Haizhi Technology Group Co., Ltd. and Jointown Pharmaceutical Group entered into a strategic cooperation framework agreement to support digital transformation in pharmaceutical distribution, including AI applications and intelligent decision support for Jointown’s supply chain.

Chuchang Investment, controlling shareholder of Jointown Pharmaceutical Group, released a pledge of 88 million shares (1.75% of total share capital) on September 23, 2026, while concert party Beijing Dianjin plans to pledge 88 million shares (1.75%) to Ping An Bank Wuhan Branch.

Beijing Haomei Digital Intelligent Medical Health Technology Co., Ltd. was established, jointly held by Beijing Haoyao Shi Pharmacy Chain Co., Ltd. (a Jiuzhoutong subsidiary) and Ningbo Niannian Youyu E-commerce Co., Ltd. (a Beingmate wholly-owned subsidiary).

On September 3, 2026, Jiuzhoutong Pharmaceutical Group signed a strategic cooperation agreement with JD Health to deepen collaboration in supply chain, fulfillment, consumer scenarios, and digital procurement.

On August 31, 2026, Shanghai Waigaoqiao Group visited Jiuzhoutong Pharmaceutical Group's Wuhan headquarters and the two parties signed a cooperation agreement covering biopharmaceutical industry ecosystem, cross-border expansion and ODI services, and industrial fund cooperation.

Jiuzhoutong signed a strategic cooperation agreement with National Pension Insurance on August 21, 2026, to collaborate in areas such as pension finance and pharmaceutical services.

Shareholder Zhongshan Guangyin of Jointown Pharmaceutical Group prematurely released a pledge of 47 million shares and pledged 17 million and 42 million shares to China Merchants Bank Wuhan Branch and Ping An Bank Wuhan Branch respectively.

Jointown Pharmaceutical Group plans to conduct domestic non-recourse seller factoring business with a total limit of up to 2.2 billion yuan at Minsheng Bank Wuhan Branch, with the limit revolving for three years from the date of shareholder approval.

Jiuzhou Tong's controlling shareholder Chuchang Investment and its concert parties partially released and newly pledged shares.

Beijing Yingnuote Biotechnology Co., Ltd. has entered into a strategic partnership with Taobao Flash Sale, Ali Health, Jointown, and Ant Afu, focusing on respiratory test reagent categories to build a full-chain instant retail ecosystem.

Haikou City Government, Hainan Medical University, and Jointown Pharmaceutical Group signed a strategic cooperation agreement to jointly build a full-chain biomedical innovation industry ecosystem.